Clinical Trials Directory

Trials / Completed

CompletedNCT05699889

Acute Kidney Dysfunction in COVID-19 and Non-COVID-19 Related ARDS

Prevalence of COVID-19-associated Kidney Injury in ICU and Prognosis of Proximal Tubular Injury in ARDS: the URICOV Study

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In addition to respiratory involvement, SARS-CoV 2, the virus responsible for coronavirus 2019 or Covid-19, appears to be responsible for renal involvement such as acute renal failure or proteinuria, so the mechanisms are not known at this time. The consequences of Covid-19 on renal function in the short and long term are not known. It is important to be able to better document these renal impairments to understand the mechanisms of this disease. The main objective of this study is to describe the prevalence of Covid-19-related renal damage (acute renal failure, proteinuria, microalbuminuria, hematuria) in a large cohort of patients in intensive care for SARS-CoV 2 infection with severe respiratory impairment. The other objectives will be to evaluate in this cohort the impact of these renal impairments on the severity of the Covid-19 disease, and to compare them to the renal impairments of patients in intensive care for acute respiratory distress syndrome (ARDS) due to other respiratory diseases. Blood and urine samples will be taken at the time of intubation in all critically ill patients with respiratory distress requiring mechanical ventilation for Covid-19 or other cause of respiratory distress with PaO2/FiO2 ratio \< 300. Patients will be followed for the duration of their ICU and hospital stay. Data will be collected prospectively in three ICUs in the University Hospitals of Marseille.

Conditions

Interventions

TypeNameDescription
OTHERData collectionacute kidney injury and tubular dysfunction

Timeline

Start date
2020-05-02
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2023-01-26
Last updated
2023-01-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05699889. Inclusion in this directory is not an endorsement.